--

12 (2) 2022

Isolation and characterization of full-length genes encoding the anti-human CD45 antibody from the hybridoma cell line 16E8-F2


Author - Affiliation:
Nguyen Quoc Huy - Biotechnology Center of Ho Chi Minh City, Ho Chi Minh City , Vietnam
Ta Huong Giang - Biotechnology Center of Ho Chi Minh City, Ho Chi Minh City , Vietnam
Nguyen Dang Quan - Biotechnology Center of Ho Chi Minh City, Ho Chi Minh City , Vietnam
Corresponding author: Nguyen Quoc Huy - nguyenquochuy213@gmail.com
Submitted: 16-09-2022
Accepted: 24-10-2022
Published: 04-11-2022

Abstract
Though the hybridoma technology has been widely applied in the production of monoclonal antibodies, it has existed some disadvantages including low yield and genetic instability. Therefore, an alternative approach should be taken into account. Recently, recombinant monoclonal antibody technology has emerged as the best choice to cure hybridoma related drawbacks. However, recombinant antibodies require known genes for their generation. The purpose of this study is to collect the full-length genes encoding the anti-human CD45 antibody derived from the hybridoma cell line 16E8-F2. In this research, we designed specific primer pairs to amplify the light and heavy chain genes of the antibody through the PCR method. Afterward, the genes were separately cloned into a cloning vector called pJET1.2/blunt. The generated recombinant pJET1.2 vectors will serve as the main material source to manufacture the recombinant monoclonal antibody recognizing human CD45 protein tomorrow.

Keywords
anti-human CD45 antibody; CD45; HC gene; hybridoma; LC gene

Full Text:
PDF

Cite this paper as:

Nguyen, H. Q., Ta, G. H., & Nguyen, Q. D. (2022). Isolation and characterization of full-length genes encoding the anti-human CD45 antibody from the hybridoma cell line 16E8-F2. Ho Chi Minh City Open University Journal of Science – Engineering and Technology, 12(2), 50-59. doi:10.46223/HCMCOUJS.tech.en.12.2.2319.2022


References

Abcam. (2018). Recombinant antibodies: Highly reproducible with tailored specificity. Retrieved December 29, 2021, from https://www.abcam.com/primary-antibodies/recombinant-antibodies


Babrak, L., McGarvey, J. A., Stanker, L. H., & Hnasko, R. (2017). Identification and verification of hybridoma-derived monoclonal antibody variable region sequences using recombinant DNA technology and mass spectrometry. Molecular Immunology, 90, 287-294.


Carroll, W. L., Mendel, E., & Levy, S. (1988). Hybridoma fusion cell lines contain an aberrant kappa transcript. Molecular Immunology, 25(10), 991-995.


Costa, A. R., Rodrigues, M. E., Henriques, M., Azeredo, J., & Oliveira, R. (2010). Guidelines to cell engineering for monoclonal antibody production. European Journal of Pharmaceutics and Biopharmaceutics, 74(2), 127-138.


Echko, M., & Dozier, S. (2010). Recombinant antibody technology for the production of antibodies without the use of animals. Retrieved December 29, 2021, from http://alttox.org/recombinant-antibody-technology-for-the-production-of-antibodies-without-the-use-of-animals/


Froger, A., & Hall, J. E. (2007). Transformation of plasmid DNA into E. coli using the heat shock method. Journal of Visualized Experiments, (6), Article 253.


Groff, K., Brown, J., & Clippinger, A. J. (2015). Modern affinity reagents: Recombinant antibodies and aptamers. Biotechnology Advances, 33(8), 1787-1798.


Hnasko, R. M., & Stanker, L. H. (2015). Hybridoma technology. Methods in Molecular Biology, 1318, 15-28.


IMGT. (n.d.). Retrieved December 29, 2021, from http://www.imgt.org/


Johnson, M., & Bradbury, A. (2015). Recombinant antibodies. Materials and Methods, 5, Article 1297.


Karu, A. E., Bell, C. W., & Chin, T. E. (1995). Recombinant antibody technology. Institute for Laboratory Animal Research Journal, 37(3), 132-141.


Liu, J. K. (2014). The history of monoclonal antibody development - Progress, remaining challenges and future innovations. Annals of Medicine and Surgery, 3(4), 113-116.


MUSCLE. (n.d.). Retrieved December 29, 2021, from https://www.ebi.ac.uk/Tools/msa/muscle/


NCBI. (n.d.). Retrieved December 29, 2021, from https://www.ncbi.nlm.nih.gov/


Pasqualini, R., & Arap, W. (2004). Hybridoma-free generation of monoclonal antibodies. Proceedings of the National Academy of Sciences of the United States of America, 101(1), 257-259.


Steinitz, M. (2009). Three decades of human monoclonal antibodies: Past, present and future developments. Human Antibodies, 18(1/2),1-10.


Ta, G. H., Nguyen, H. Q., & Nguyen, Q. D. (2020). Generating and characterizing the anti-human CD45 monoclonal antibody. Science and Technology Development Journal, 23(3), 665-672.


Wang, S. (2011). Advances in the production of human monoclonal antibodies. Antibody Technology Journal, 1, 1-4.



DOI: https://doi.org/10.46223/HCMCOUJS.tech.en.12.2.2319.2022
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.